tiprankstipranks
Trending News
More News >

Fisher & Paykel Healthcare downgraded to Underperform at RBC Capital

RBC Capital downgraded Fisher & Paykel Healthcare to Underperform from Sector Perform with a price target of NZ$29, down from NZ$30. The downgrade follows the company’s FY25 results, which exceeded both RBC and consensus expectations, but showed a “significant slowdown” in revenue growth of hospital new application consumables and homecare consumables. The firm cited the stock’s “expensive valuation relative to its earnings outlook” for the downgrade.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1